EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-Metaanalyse

Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta‐analysis

Wenjuan He iD, Yuqian Zhang iD, Guangliang Huang iD, Yunfei Tian iD, Qian Sun iD, Xiuju Liu iD

LUTS: Lower Urinary Tract Symptoms · 2023-05 · 15 (3) · 80-88

DOI: 10.1111/luts.12475 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift LUTS: Lower Urinary Tract Symptoms, online erschienen am 02.03.2023. Verfasst von Wenjuan He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Hospital of HeBei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this study was to indirectly compare the efficacy and safety of mirabegron and vibegron in patients with overactive bladder.

Methods

A systematic search was performed on Pubmed, Web of Science, Embase, and the Cochrane Central Register of Controlled Trials databases to identify studies from the date of database inception to January 1, 2022. All randomized controlled trials comparing mirabegron or vibegron with tolterodine, imidafenacin, or placebo were eligible. One reviewer extracted data, and a second reviewer checked. Included trials were assessed for similarity, and networks were developed using Stata 16.0 software. Mean differences for continuous variables and odds ratios for dichotomous variables together with their 95% confidence intervals (CIs) were used to rank treatments and compare the differences, respectively.

Results

A total of 11 randomized controlled trials and 10 806 patients were included. For each outcome, results for all licensed treatment doses were included. Both vibegron and mirabegron were more efficacious than placebo at reducing the frequency of micturition, incontinence, urgency, urgency incontinence, and nocturia. Vibegron was more efficacious than mirabegron in reducing mean voided volume/micturition (95% CI [5.15, 14.98]). Safety outcomes for vibegron and mirabegron were similar to those in the placebo group, except for mirabegron, which had a higher risk of nasopharyngitis and cardiovascular adverse events than placebo.

Conclusions

Both drugs seem to be comparable and well tolerated, particularly as direct comparisons are not available. However, vibegron may be more effective than mirabegron in reducing mean voided volume.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder, OveractiveHumansTreatment OutcomeDouble-Blind MethodAcetanilidesAdrenergic beta-3 Receptor AgonistsRandomized Controlled Trials as TopicThiazolesPyrimidinonesPyrrolidines

Stichwörter der Autor:innen

mirabegronnetwork meta-analysisoveractive bladderrandomized controlled trialsvibegron

Substanzen

AcetanilidesAdrenergic beta-3 Receptor AgonistsmirabegronThiazolesN-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carbo…PyrimidinonesPyrrolidines

Autor:innen und Institutionen

  • Department of Pharmacy, The Second Hospital of HeBei Medical University, Shijiazhuang, China.
  • Department of Clinical Pharmacy, HeBei Medical University, Shijiazhuang, China.
  • Department of Psychology, The University of Hong Kong, Hong Kong, China.

ORCID-Profile: Wenjuan He, Yuqian Zhang, Guangliang Huang, Yunfei Tian, Qian Sun, Xiuju Liu

Zitieren

APA

He, W., Zhang, Y., Huang, G., Tian, Y., Sun, Q., & Liu, X. (2023). Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta‐analysis. LUTS: Lower Urinary Tract Symptoms, 15(3), 80-88. https://doi.org/10.1111/luts.12475

Vancouver

He W, Zhang Y, Huang G, Tian Y, Sun Q, Liu X. Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta‐analysis. LUTS: Lower Urinary Tract Symptoms. 2023;15(3):80-88. doi:10.1111/luts.12475

BibTeX
@article{He2023,
  author = {He, Wenjuan and Zhang, Yuqian and Huang, Guangliang and Tian, Yunfei and Sun, Qian and Liu, Xiuju},
  title = {Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta‐analysis},
  journal = {LUTS: Lower Urinary Tract Symptoms},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {80--88},
  doi = {10.1111/luts.12475}
}
Kostenlos starten →